CD8A and neoplasm: To examine whether the observed difference in tumor growth in vivo was associated with distinct cell infiltrates, we examined fractions of CD4+ and CD8+ T cells, NK cells and T regularity (Treg) cells in shLDH-A deficient and control B16-F10 tumors (Figure 2).